Trials / Completed
CompletedNCT00666016
Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Double-Blind vs Placebo, Randomized, Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 500 mg QD for One Month in Patients With Non-Alcoholic Steatohepatitis (NASH)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety, the tolerability and the short term effect on liver enzymes of TRO19622 500 mg for one month in patients with Non-Alcoholic Steatohepatitis (NASH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TRO19622 | TRO19622 500 mg once a day before noon meal during 6 weeks |
| DRUG | Placebo |
Timeline
- Start date
- 2008-04-15
- Primary completion
- 2009-02-05
- Completion
- 2009-02-05
- First posted
- 2008-04-24
- Last updated
- 2025-12-18
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00666016. Inclusion in this directory is not an endorsement.